+Compare
VVOS
Stock ticker:
NASDAQ
AS OF
Aug 5 closing price
Price
$1.31
Change
-$0.06 (-4.38%)
Capitalization
30.15M

VVOS Price Prediction, Vivos Therapeutics AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Aug 05, 2022

Momentum Indicator for VVOS turns negative, indicating new downward trend

VVOS saw its Momentum Indicator move below the 0 level on July 22, 2022. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator turned negative. In 24 of the 24 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for VVOS turned negative on July 28, 2022. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 12 similar instances when the indicator turned negative. In of the 12 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VVOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VVOS's RSI Indicator exited the oversold zone, of 15 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 17 cases where VVOS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VVOS advanced for three days, in of 65 cases, the price rose further within the following month. The odds of a continued upward trend are .

VVOS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.446) is normal, around the industry mean (17.059). P/E Ratio (0.000) is within average values for comparable stocks, (93.546). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.752). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (1.705) is also within normal values, averaging (92.278).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VVOS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VVOS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

VVOS is expected to report earnings to rise 3.85% to -27 cents per share on August 11

Vivos Therapeutics VVOS Stock Earnings Reports
Q2'22
Est.
$-0.27
Q1'22
Est.
$-0.26
Q4'21
Missed
by $0.07
Q3'21
Missed
by $0.07
Q2'21
Missed
by $0.01
The last earnings report on May 16 showed earnings per share of -25 cents, meeting the estimate of -25 cents. With 12.01K shares outstanding, the current market capitalization sits at 30.15M.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Edwards Lifesciences Corp (NYSE:EW), Boston Scientific Corp (NYSE:BSX), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.23B. The market cap for tickers in the group ranges from 775 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is BIIO at 775.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 6%. For the same Industry, the average monthly price growth was 9%, and the average quarterly price growth was -16%. APDN experienced the highest price growth at 722%, while HSDT experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 55%. For the same stocks of the Industry, the average monthly volume growth was 3% and the average quarterly volume growth was 55%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 73
Price Growth Rating: 53
SMR Rating: 67
Profit Risk Rating: 83
Seasonality Score: 2 (-100 ... +100)
AI

View a ticker or compare two or three

AI
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
9137 Ridgeline Boulevard
Phone
+1 844 672-4357
Employees
167
Web
https://www.vivos.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VSTM1.190.06
+5.31%
Verastem
ACA60.441.51
+2.56%
Arcosa
AGRI1.790.03
+1.70%
AgriFORCE Growing Systems Ltd
PBT17.920.08
+0.45%
Permian Basin Royalty Trust
BBY76.380.09
+0.12%
Best Buy Company

VVOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VVOS has been loosely correlated with BWAY. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if VVOS jumps, then BWAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VVOS
1D Price
Change %
VVOS100%
-4.38%
BWAY - VVOS
34%
Loosely correlated
+4.27%
BNGO - VVOS
32%
Poorly correlated
+2.55%
ACRS - VVOS
31%
Poorly correlated
+7.33%
VNRX - VVOS
31%
Poorly correlated
-0.98%
MDGS - VVOS
30%
Poorly correlated
-3.16%
More